RESOURCES AND ADDITIONAL INFORMATION

The following is a list of sites and articles with comprehensive information on MS. We encourage you to explore these and other sites, as well as talk to you your doctor to better inform you of your disease.

National MS Societies

American Academy of Neurology

• https://www.aan.com

The Consortium of Multiple Sclerosis Centers

• http://www.mscare.org

National Multiple Sclerosis Society

• http://www.nationalmssociety.org

Multiple Sclerosis Association of America

• http://www.mymsaa.org

Multiple Sclerosis Foundation

• http://www.msfocus.org

National Institute of Neurological Disorders and Stroke

• http://www.ninds.nih.gov/index.htm

Frequently Asked Questions

National Multiple Sclerosis Society. Multiple Sclerosis: Frequently Asked Questions. Available at:

• http://www.nationalmssociety.org/What-is-MS/MS-FAQ-s#question-What-is-multiple-sclerosis

Multiple Sclerosis Foundation. Multiple Sclerosis FAQs. Available at:

• http://www.msfocus.org/multiple-sclerosis-faqs.aspx

Multiple Sclerosis Association of America. Frequently Asked Questions about Multiple Sclerosis. Available at:

• http://www.mymsaa.org/about-ms/faq/

WebMD. Frequently Asked Questions about Multiple Sclerosis. Available at:

• http://www.webmd.com/multiple-sclerosis/guide/multiple-sclerosis-faq

Additional Reading

1. Karussis D. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. J Autoimmun. 2014;48-49:134-42. http://www.ncbi.nlm.nih.gov/pubmed/24524923
2. Lublin FD, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology.2014;83(3):278-86. http://www.ncbi.nlm.nih.gov/pubmed/24871874
3. Marcus JF, et al. Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis. Neurohospitalist. 2013;3(2):65-80. http://www.ncbi.nlm.nih.gov/pubmed/23983889
4. Polman C, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.Ann Neurol. 2011;69(2):292-302. http://www.ncbi.nlm.nih.gov/pubmed/21387374
5. Sormani MP, et al. Can we measure long-term treatment effects in multiple sclerosis? Nat Rev Neurol. 2015;11(3):176-82.http://www.nature.com/nrneurol/journal/v11/n3/full/nrneurol.2014.237.html
6. Tanasescu R, et al. Advances in the treatment of relapsing-remitting multiple sclerosis. Biomed J.2014;37(2):41-9. http://www.ncbi.nlm.nih.gov/pubmed/24732658
7. Toosy A, et al. Symptomatic treatment and management of multiple sclerosis. Handb Clin Neurol.2014;122:513-62. http://www.ncbi.nlm.nih.gov/pubmed/24507534
8. Turner AP, et al. Injection anxiety remains a long-term barrier to medication adherence in multiple sclerosis. Rehabil Psychol. 2009;54:116–121. http://www.ncbi.nlm.nih.gov/pubmed/19618711